Dr. John Norian was recently featured in an article on Medscape written by Sara Novak titled “GLP-1 Agonists and Fertility: What Physicians Need To Know.”

As stated in the article, the use of glucagon-like peptide 1 (GLP-1) medications amongst women have increased dramatically in recent years. From 2020 to 2023, the rate of young women taking these medications increased by 594%.

The article goes on to talk about how GLP-1s affect fertility. Fertility hormones work better when insulin is working more efficiently through the use of these medications, said John Norian, MD, a board-certified reproductive endocrinologist with HRC Fertility in Pasadena and Rancho Cucamonga, California. “The pituitary gland communicates better with the ovaries, which allows a mature dominant follicle to release a mature, healthy egg,” said Norian.

Furthermore, the article discusses GLP-1s and their effect on unplanned pregnancies, potential risks during pregnancy, and effects during in-vitro fertilization (IVF). To learn more about GLP-1 agonists, read the article in its entirety here.